Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Leukemia
|
March 10, 2001
Percentage of activated cytotoxic T-lymphocytes in anaplastic large cell lymphoma and Hodgkin's disease: an independent biological prognostic marker
R L ten Berge, J J Oudejans, D F Dukers, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 6, 2000
Direct immunosuppressive effects of EBV-encoded latent membrane protein 1
D F Dukers, P Meij, M B Vervoort, et al.
The Journal of Pathology
|
February 5, 2000
Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease
D F Dukers, L H Jaspars, W Vos, et al.
Histopathology
|
June 10, 2000
All infiltrating T-lymphocytes in Hodgkin's disease express immunohistochemically detectable T-cell receptor zeta-chains in situ
D F Dukers, J J Oudejans, E H Jaspars, et al.
Journal of Clinical Pathology
|
March 17, 2001
Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype
D F Dukers, M H Vermeer, L H Jaspars, et al.
Journal of Clinical Pathology
|
February 14, 1998
Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas
A A Brink, D F Dukers, A J van den Brule, et al.
Journal of Clinical Pathology
|
March 16, 2002
Differential expression of cell cycle and apoptosis related proteins in colorectal mucosa, primary colon tumours, and liver metastases
H H J Backus, C J Van Groeningen, W Vos, et al.
Seminars in Cancer Biology
|
August 1, 1996
Epstein-Barr virus and human T-cell lymphomas
C J Meijer, N M Jiwa, D F Dukers, et al.
Blood
|
April 9, 1999
Adverse effects of activated cytotoxic T lymphocytes on the clinical outcome of nodal anaplastic large cell lymphoma
R L ten Berge, D F Dukers, J J Oudejans, et al.
Journal of Clinical Pathology
|
May 1, 1995
Immunohistochemical demonstration of different latent membrane protein-1 epitopes of Epstein-Barr virus in lymphoproliferative diseases
N M Jiwa, J J Oudejans, D F Dukers, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Leukemia
|
March 10, 2001
Percentage of activated cytotoxic T-lymphocytes in anaplastic large cell lymphoma and Hodgkin's disease: an independent biological prognostic marker
R L ten Berge, J J Oudejans, D F Dukers, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 6, 2000
Direct immunosuppressive effects of EBV-encoded latent membrane protein 1
D F Dukers, P Meij, M B Vervoort, et al.
The Journal of Pathology
|
February 5, 2000
Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease
D F Dukers, L H Jaspars, W Vos, et al.
Histopathology
|
June 10, 2000
All infiltrating T-lymphocytes in Hodgkin's disease express immunohistochemically detectable T-cell receptor zeta-chains in situ
D F Dukers, J J Oudejans, E H Jaspars, et al.
Journal of Clinical Pathology
|
March 17, 2001
Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype
D F Dukers, M H Vermeer, L H Jaspars, et al.
Journal of Clinical Pathology
|
February 14, 1998
Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas
A A Brink, D F Dukers, A J van den Brule, et al.
Journal of Clinical Pathology
|
March 16, 2002
Differential expression of cell cycle and apoptosis related proteins in colorectal mucosa, primary colon tumours, and liver metastases
H H J Backus, C J Van Groeningen, W Vos, et al.
Seminars in Cancer Biology
|
August 1, 1996
Epstein-Barr virus and human T-cell lymphomas
C J Meijer, N M Jiwa, D F Dukers, et al.
Blood
|
April 9, 1999
Adverse effects of activated cytotoxic T lymphocytes on the clinical outcome of nodal anaplastic large cell lymphoma
R L ten Berge, D F Dukers, J J Oudejans, et al.
Journal of Clinical Pathology
|
May 1, 1995
Immunohistochemical demonstration of different latent membrane protein-1 epitopes of Epstein-Barr virus in lymphoproliferative diseases
N M Jiwa, J J Oudejans, D F Dukers, et al.
Page
of 2